Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Interim Data...

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 29, 2023 5:07pm

320 Views

Post# 35610726

RE:RE:RE:RE:RE:Interim Data...

Pretty stable and awesome data. 270 days is looking better. especially when combining CR plus IR, and overall with optimized treatment we can see we would get about 5-10% increase in CR in the end. So I'm expecting overall after 100 patients about 45% CR at 450 days. It could end up higher, but I will be happy with anything over 35%. We are clearly over 30% benchmark. BTD is taking a bit longer, but at least the FDA is getting familiar with our tech and data with all these back and forths.. This tells me that AA could follow shortly after. All IMHO

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch